quinuclidines has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Tan, HB; Zhao, Q | 1 |
| Ellis, CA; Mann, TA; Villani, FJ; Wefer, EA | 1 |
2 other study(ies) available for quinuclidines and Diabetes Mellitus
| Article | Year |
|---|---|
Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2.
Topics: Animals; Caspase 1; Diabetes Mellitus; Diabetic Nephropathies; Female; Fibrinogen; Humans; Inflammation; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Quinuclidines; Rats; Toll-Like Receptor 4 | 2022 |
Derivatives of 2-azabicyclo[2.2.2]octane. 3. Substituted phenylsulfonylcarbamoyl derivatives.
Topics: Alkanes; Animals; Blood Glucose; Bridged-Ring Compounds; Chemical Phenomena; Chemistry; Diabetes Mellitus; Diazoxide; Hypoglycemic Agents; Mice; Quinuclidines | 1969 |